Nonmelanoma skin cancer

Clin Plast Surg. 2005 Apr;32(2):237-48. doi: 10.1016/j.cps.2004.11.009.

Abstract

Each year, there are as many cases of nonmelanoma skin cancer as all other cancers combined. Although there is relatively low attributable mortality, the morbidity and expense of treatment is significant. Unlike many other malignancies, host and environmental factors relevant to the pathophysiology have been clearly demonstrated. Surgical ablation remains the mainstay of treatment.

Publication types

  • Review

MeSH terms

  • Carcinoma, Basal Cell* / diagnosis
  • Carcinoma, Basal Cell* / pathology
  • Carcinoma, Basal Cell* / surgery
  • Carcinoma, Basal Cell* / therapy
  • Carcinoma, Squamous Cell* / diagnosis
  • Carcinoma, Squamous Cell* / pathology
  • Carcinoma, Squamous Cell* / surgery
  • Carcinoma, Squamous Cell* / therapy
  • Humans
  • Risk Factors
  • Skin / pathology
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / pathology
  • Skin Neoplasms* / surgery
  • Skin Neoplasms* / therapy